Article

pubs.acs.org/joc

Synthesis of Five‑, Six‑, and Seven-Membered 1,3- and 1,4-
Heterocyclic Compounds via Intramolecular Hydroalkoxylation/
Hydrothioalkoxylation of Alkenols/Thioalkenols
Manash J. Deka, Kiran Indukuri, Sabera Sultana, Madhurjya Borah, and Anil K. Saikia*

Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati-781039, India

*S Supporting Information

ABSTRACT: Intramolecular hydroalkoxylation/hydrothioal-
koxylation of nitrogen-tethered alkenes and alcohols/thiols
mediated by boron triﬂuoride etherate leads to ﬁve-membered
thiazolidine, six-membered 1,4-oxazines (morpholines) and
tetrahydro-2H-1,4-thiazines (thiomorpholines), and seven-
membered 1,4-oxazepanes in good yields.

■ INTRODUCTION

Substituted 1,4-oxazines, tetrahydro-2H-1,4-thiazines, and 1,4-
oxazepanes are widely distributed in many naturally occurring
and biologically active molecules.1 For example, reboxetine (1),
a morpholine-containing compound, shows antidepressant
properties.2 Similarly, compounds 2 and 3 possess anti-
inﬂammatory and GABAB receptor-antagonist properties.3
The 1,4-oxazepane unit is found in naturally occurring alkaloid
batrachotoxin (4), which acts as a ligand for CC chemokine
receptors, such as CCRl (Figure 1).1d,e,4 These heterocyclic

Figure 1. Biologically important morpholine and 1,4-oxazepane
derivatives.

scaﬀolds are versatile synthetic units in organic synthesis,
particularly for the construction of agrochemicals, fungicides,
and bactericides.5 1,4-Oxazines are also used as chiral
auxiliaries.6 On the other hand,
thiazolines are known as
ﬂavouring agents and are found in fruits and vegetables.7 They
are also known to possess biological activities
such as
anticancer,8 antimicrobial,9 and antihypertensive10 activity and
are used as building blocks in peptide synthesis.11

Numerous synthetic approaches have been developed for the
preparation of 1,4-oxazines and 1,4-oxazepanes, such as ring
closure of amino diols,12 amino alcohols, and bromosulfonium
salts,13 double allylic substitution by amino alcohols,14
cyclization of N-tethered halo alcohols,15 reductive amination
of diketones,16 reductive etheriﬁcation of N-tethered keto
alcohols,17 cyclization of O-protected amino alcohols,18 oxirane
ring opening by tosylamide and subsequent cyclization,19 and
ring opening of aziridines.20 Recently, Chemler and co-workers
have reported the synthesis of 1,4-oxazines via intramolecular
cyclization of N-tethered alkene−alkanol mediated by copper.21
The thiazolidines are synthesized by the Asinger method, a
multicomponent reaction between an α-mercapto ketone, an
aldehyde, and ammonia.22 Another method is condensation of
cysteine and aldehydes.23 These methods have their own merits
and demerits, but some of them suﬀer from serious problems
such as lack of selectivity,23a,c low yields,15c,16,19 and harsh
reaction conditions.21 Moreover,
intramolecular hydroalkox-
ylation/hydrothioalkoxylation reactions are currently of great
interest for the synthesis of ﬁve- and six-membered cyclic ethers
and thioethers using γ- and δ-hydroxy/thio oleﬁns in the
presence of transition-metal and lanthanide catalysts such as
[PtCl2(H2CCH2)]2, AgOTf, Ph3PAuOTf, Au nanocluster
·7H2O−NaI, Ln(OTf)3, In(OTf)3, and Yb-
(Au/PVP), CeCl3
·OEt2 has been used for the synthesis of
(OTf)3.24 Similarly, BF3
tetrahydrocannabinols and cannabinoid derivatives and in the
total synthesis of quinone and hydroquinone sesquiterpenes via
intermolecular addition of phenol to alkene.25 However, the use
·OEt2 in intramolecular hydroalkoxylation/hydrothioal-
of BF3
koxylation reaction for the synthesis of ﬁve-, six-, and seven-
membered 1,3- and 1,4-heterocyclic compounds has not been
reported so far. We now present a general and transition-metal-
free methodology for
the synthesis of 1,4-oxazines, 1,4-
oxazepanes, and thiazolidines using intramolecular hydro-
alkoxylation/hydrothioalkoxylation of alkenols/thioalkenols

Received:
January 8, 2015
Published: April 10, 2015

© 2015 American Chemical Society

4349

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Article

Scheme 1. Synthesis of Starting Materials

mediated by boron triﬂuoride etherate at ambient temperature
in moderate to good yields.

■ RESULTS AND DISCUSSION
<para sub=“opt”>
In continuation of our
in oxygen and nitrogen
heterocycles,26 we were in search of synthesizing heterocyclic
frameworks having two heteroatoms. To start with, alkenol 5d
was treated with 1.2 equiv of boron triﬂuoride etherate in
dichloromethane at room temperature for 5 h, and 2-methyl-2-
phenyl-4-tosylmorpholine 6d was obtained in 90% yield. The
reaction was also performed in diﬀerent Lewis and Brønsted
acidic conditions, and the results are shown in Table 1. The
</para>
interest

Table 1. Optimization of the Reaction Conditionsa

reagent

conversionb

·7H2O (1.2)

entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

solvent
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
toluene
CH3CN
THF

(amt, mmol)
·OEt2 (1.2)
BF3
·OEt2 (0.5)
BF3
Zn(OTf)2 (0.2)
Cu(OTf)2 (0.2)
ln(OTf)3 (0.2)
Ag(OTf)2 (0.2)
InCl3 (0.2)
CeCl3
FeCl3 (1.2)
TsOH (1.2)
CSA (1.2)
TfOH (1.2)
HF (1.2)
BF3
BF3
BF3

(%)
100
44
g
0
36
0
0
0
0
22
34
63
0
70
35
61
aReaction conditions: alkenol (1.0 mmol),
solvent (5 mL).
bDetermined by 1H NMR. cYield refers to isolated yield. dNo
reaction; starting material was recovered.

·OEt2 (1.2)
·OEt2 (1.2)
·OEt2 (1.2)

yieldc
(%)
90
38
5
d
30
d
d
d
d
19
26
52
d
72
26
53

time
(h)
5
12
24
24
24
24
24
24
24
24
24
24
24
12
12
12
<para sub=“opt”>
·OEt2 furnished only 38% yield
reaction with 0.5 equiv of BF3
over 12 h. Metal triﬂates such as zinc, copper, indium, and silver
triﬂates were also screened for the reaction. Out of these, only
zinc and indium triﬂates gave 5% and 30% yields, respectively.
·7H2O, and FeCl3 failed to
Similarly, metal salts InCl3, CeCl3
give the desired product, but starting material was recovered in
98% yield. Brønsted acids such as toluenesulfonic acid (TsOH),
camphorsulfonic acid (CSA), and triﬂic acid (TfOH) gave 19%,
26%, and 52% yields, respectively, whereas HF did not work.
The reaction was also screened in other solvents such as
toluene (entry 14), acetonitrile (entry 15), and THF (entry
16), and gave 72%, 26%, and 53% yields,
respectively.
·Et2O in CH2Cl2 at room temperature was
Therefore, BF3
found to be the best conditions for this reaction.
</para>
<para sub="scope">
Having obtained the optimized conditions, we further
examined the scope of the reaction with a variety of substrates,
which were synthesized according to the literature methods
either by allylation of N-tosylamino alcohols/thiols or by
substitution reaction between phenylacetyl bromide and N-
allyl/homoallyltosylamide followed by the reduction of the
ketone (Scheme 1).27
</para>
<para sub="scope">
It was observed from Table 2 that primary and secondary
alkenols 5a−5l (entries 1−12) having alkyl- and aryl-
substituted oleﬁnic groups gave the desired 1,4-oxazines in
good yields. In the case of secondary alkenols, the substrates
having electron-withdrawing aromatic substituents (entries 7−
11) gave good yields, whereas electron-donating-aromatic-
substituted alkenol 5l decomposed under
these reaction
conditions (entry 12). The chiral substrates 5e and 5f (entries
5 and 6) gave single diastereomers with 2-alkyl and 5-phenyl
groups cis to each other. Similarly, the secondary alkenols 5g,
5i, and 5j also produced exclusively single diastereomers having
a cis relationship between the phenyl groups at the 2- and 6-
positions. The cis stereochemistry was conﬁrmed by the X-ray
crystallographic structures of 6f,g (Figure 2).28
</para>
<para sub="scope">
This method also worked well for the phenolic compound
5m (entry 13) and gave 2-methyl-2-phenyl-4-tosyl-3,4-dihydro-
2H-benz[b][1,4]oxazine (6m) in 68% yield. Similarly, alkenols
5n−5q (entries 14−17) gave the corresponding 1,4-oxazepanes
6n−6q in good yields. The isomeric alkenols 5n and 5o gave
the same product, 6n. On the other hand, a substrate having a
terminal alkene, 5r (entry 18), was unreactive under the same
reaction conditions, and starting material was recovered in 98%.
</para>
<para sub="scope">
After successful study of this methodology for the synthesis
of 1,4-oxazines and oxazepanes, its application to the synthesis
of 1,4-thiazines and thiazepanes was explored. The starting
material thioalkenes 5s,t (Table 3, entries 1 and 2) when
treated with boron triﬂuoride etherate under the same reaction
conditions gave 2-methyl-2-phenyl-4-tosylthiomorpholine (6s)
and 2,5-dimethyl-2-phenyl-4-tosylthiomorpholine (6t) in 70%
and 73% yields, respectively. On the other hand, substrates 5u−
x (Table 3, entries 3−6) having substitution at the α-position to
the N-tosyl group gave thiazolidines 7u−x (Table 3) in 66%,
71%, 59%, and 74% yields, respectively. Substrates 5v and 5x
(entries 4 and 6) gave two inseparable diastereomers, 7v and
7x, in 71% and 74% overall yield, respectively. The substrate 5w
gave hydrolyzed product 7w under these reaction conditions.
On the other hand, 5x having hydroxyl and thiol groups gave
thiazolidine 7x selectively, without formation of any morpho-
line products. The stereochemistry of the thiazolidine was
determined by 1H NMR and NOE experiments of 7u (Figure
3). There is a strong NOE between protons at C-2 and C-4 of
7u, which conﬁrms that they are cis to each other.
</para>
their
<para sub=“ques”>
The exact mechanism of formation of 1,4-oxazines and 1,4-
oxazepanes or
sulfur analogues via intramolecular
hydroalkoxylation/hydrothioalkoxylation of alkenols/thioalke-
nols mediated by boron triﬂuoride etherate is not known, but
mechanisms for the hydroalkoxylation of alkenols promoted by
transition metal or
lanthanide reagents are proposed by
</para>
4350

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Table 2. Synthesis of 1,4-Oxazines and 1,4-Oxazepanes

Article

4351

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Table 2. continued

Article

aYields refer to the isolated yield. The compounds were characterized by IR, NMR, and mass spectrometry.
<para sub=“ques”>
be explained as follows. First thiol reacts with boron triﬂuoride
etherate to form intermediate C, an ion pair, the proton of
which adds to the double bond to give carbocation D, which is
similar to intermediate B. This intermediate D undergoes a 1,2-
to give rearranged carbocation E, which is
hydride shift
stabilized by ester or hydroxyl groups present at position 2.
Finally, the thiol group attacks the carbocation E to give more
stable ﬁve-membered compounds 7u−x (Scheme 2, mechanism
II).24k The presence of ester and hydroxyl groups at the 2-
position is crucial for the formation of the ﬁve-membered ring,
which can be exempliﬁed by the fact that compound 5t having a
methyl group at the 2-position gave six-membered ring 6t.
</para>

■ CONCLUSIONS

In conclusion, we have developed a mild and eﬃcient general
method for the synthesis of substituted 1,4-oxazines, 1,4-
oxazepanes, 1,4-thiazines and thiazolidines via intramolecular
cyclization reaction of alkenols/thioalkenols in good yields and
excellent diastereoselectivity. The reaction is highly atom
economic and compatible with a wide range of
functional
groups, such as ester, hydroxy, −CF3, bromo, and alkyne.
Furthermore, N-tethered alkenthiol having substituents at the
α-position to nitrogen provides excellent access to a diverse
array of thiazolidine derivatives with a 2,4-cis relationship.

4352

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

Figure 2. ORTEP diagram of compounds 6f and 6g.
<para sub=“ques”>
diﬀerent groups, where the metal forms a coordinated complex
with alcohols and oleﬁnic groups.21 The same mechanism
cannot be applied in this case as boron cannot form such a type
of complex. An alternative mechanism is proposed which can
be explained as follows. The alkenols/thioalkenols 5 react with
boron triﬂuoride etherate to form intermediate A, an ion pair,
the proton of which adds to the double bond to give more
stable carbocation B. The carbocation B is then attacked by
alkoxide/ion to form 1,4-oxazines, 1,4-oxazepanes, and
thiazines (Scheme 2, mechanism I). This explains
the
formation of product by the substrate 5r,
incapability of
where the carbocation B is not stable. On the other hand, the
mechanism for the formation of thiazolidine products 7u−x can
</para>
The Journal of Organic Chemistry

Table 3. Synthesis of Tetrahydro-2H-1,4-thiazines and Thiazolidines

Article

aYield refers to the isolated yield. All the products were characterized by 1H and 13C NMR and mass spectrometry. bThe reaction took 12 h.
cInseperable mixture of diastereomers with a ratio of 7:3. The ratio is determined by 1H NMR. dInseperable mixture of diastereomers with a ratio of
3:2. The ratio is determined by 1H NMR.

Figure 3. NOE diagram of compound 7u.

■ EXPERIMENTAL SECTION
<para sub=“exp”>
General Information. All the reagents were of analytical reagent
(AR) grade and were used as purchased without further puriﬁcation.
Silica gel (60−120 mesh size) was used for column chromatography.
Reactions were monitored by TLC on silica gel GF254 (0.25 mm).
Melting points were recorded in an open capillary tube and are
uncorrected. Fourier
transform infrared (FT-IR) spectra were
recorded as neat liquid or KBr pellets. NMR spectra were recorded
in CDCl3 with tetramethylsilane as the internal standard for 1H (600
MHz, 400 MHz) and 13C (150 MHz, 100 MHz) NMR. Chemical
shifts (δ) are reported in parts per million, and spin−spin coupling
constants (J) are given in hertz. HRMS spectra were recorded using a
Q-TOF mass spectrometer.
Synthesis of Starting Materials. General Procedure for the
Synthesis of Starting Materials 5a−f, 5h−o, and 5q−x. Amino
alcohols and thiols 8a−f, 8h−o, and 8q−x (1.0 equiv) in anhydrous
DMF were added to a stirred solution of sodium hydride (1.2 equiv)
in dry DMF under an inert atmosphere at 0 °C. After complete
evolution of hydrogen gas, substituted allyl bromide (1.0 equiv) in

DMF was added dropwise for 10 min, and the reaction was stirred at
room temperature for 16 h. After completion of the reaction, brine
solution was added to the reaction mixture, and the reaction mixture
was extracted with ethyl acetate. The organic layer was further washed
with brine solution 2−3 times. The combined organic layers were
dried over Na2SO4 and concentrated in a rotary evoparator. The
obtained crude was subjected to column chromatography over silica
gel, giving corresponding products 5a−f, 5h−o, and 5q−x.

General Procedure for the Synthesis of Starting Materials 5g,p.
Tosyl amides 9g,p (1.0 equiv) in anhydrous DMF were added to a
stirred solution of sodium hydride (1.2 equiv) in dry DMF under an
inert atmosphere at 0 °C. After complete evolution of hydrogen gas,
bromoacetophenone (1.0 equiv) in DMF was added dropwise for 10
min, and the reaction was stirred at room temperature for 10 h. After
completion of the reaction, brine solution was added to the reaction
mixture, and the reaction mixture was extracted with ethyl acetate. The
organic layer was further washed with brine solution (2 × 15 mL). The
combined organic layers were dried over Na2SO4 and concentrated in
a rotary evaporator. The crude was subjected to column chromatog-
raphy over silica gel, giving corresponding products 10g,p.

10g,p (1.0 equiv) in dry THF was added to a stirred suspension of
LAH (1.0 equiv) in THF at 0 °C. The reaction mixture was stirred at
room temperature for 5 h, after which the reaction mixture was
quenched with 2 N NaOH, passed through a Celite pad, and washed
with ethyl acetate. The mixture was treated with brine and extracted
with EtOAc, and the combined organic extracts were dried over
anhydrous Na2SO4, ﬁltered, and concentrated in vacuo. The crude
</para>
4353

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Scheme 2. Plausible Mechanism of the Reaction

Article

Data for
<para sub=“exp”>
product was puriﬁed using column chromatography to give
compounds 5g,p.
Data for N-(2-hydroxyethyl)-4-methyl-N-(2-methylallyl)-
benzenesulfonamide (5a): white solid; mp 74−76 °C; Rf (hexane/
EtOAc, 7:3) 0.47; yield 393 mg, 73%; 1H NMR (400 MHz, CDCl3) δ
1.70 (s, 3 H), 2.40 (s, 3 H), 3.15 (t, J = 5.6 Hz, 2 H), 3.65 (t, J = 5.6
Hz, 2 H), 3.68 (s, 2 H), 4.84 (s, 1 H), 4.88 (s, 1 H), 7.28 (d, J = 7.6
Hz, 2 H), 7.68 (d, J = 8.8 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ
20.0, 21.7, 50.6, 56.4, 61.2, 115.0, 127.5, 129.9, 136.0, 141.0, 143.8; IR
(KBr, neat) 3440, 2924, 1334, 1159, 1020, 708 cm−1; HRMS (ESI) m/
z calcd for C13H20NO3S (M + H)+ 270.1158, found 270.1157.

(R)-N-(2-hydroxy-1-phenylethyl)-4-methyl-N-(2-
methylallyl)benzenesulfonamide (5b): colorless gum; Rf (hexane/
25 = −81.0 (c = 0.15,
EtOAc, 7:3) 0.54; yield 566 mg, 82%; [α]D
CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 1.68 (s, 3 H), 2.45 (s, 3 H),
3.32 (d, J = 16.0 Hz, 1 H), 3.93 (d, J = 16.0 Hz, 1 H), 4.02 (dd, J =
11.2 and 6.0 Hz, 1 H), 4.16 (dd, J = 11.2 and 8.8 Hz, 1 H), 4.82 (s, 1
H), 4.87 (s, 1 H), 4.95 (dd, J = 8.8 and 6.4 Hz, 1 H), 6.83 (d, J = 7.6
Hz, 2 H), 7.16−7.27 (m, 3 H), 7.29 (d, J = 8.0 Hz, 2 H), 7.71 (d, J =
8.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 20.0, 21.7, 51.3, 62.8,
62.9, 114.0, 127.5, 128.5, 128.6, 128.8, 129.9, 135.2, 138.0, 142.6,
143.7; IR (KBr, neat) 3532, 2953, 2925, 1742, 1658, 1439, 1339, 1159,
1093, 816, 709 cm−1; HRMS (ESI) m/z calcd for C19H24NO3S (M +
H)+ 346.1471, found 346.1477.

Data for

(S)-methyl 3-hydroxy-2-(4-methyl-N-(2-methylallyl)-
benzenesulfonamido)propanoate (5c): pale yellow oil; Rf (hexane/
25 = −29.0 (c = 0.1,
EtOAc, 7:3) 0.46; yield 432 mg, 66%; [α]D
CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 1.67 (s, 3 H), 2.43 (s, 3 H),
3.59 (s, 3 H), 3.75 (d, J = 16.2 Hz, 1 H), 3.82 (dd, J = 11.4 and 6.0 Hz,
1 H), 3.92 (d, J = 15.6 Hz, 1 H), 4.10−4.14 (m, 1 H), 4.41 (t, J = 6.6
Hz, 1 H), 4.94 (s, 1 H), 5.00 (s, 1 H), 7.30 (d, J = 7.8 Hz, 2 H), 7.73
(d, J = 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 20.0, 21.7, 52.3,
53.5, 61.0, 61.7, 114.9, 127.8, 129.7, 136.8, 141.6, 143.9, 170.4; IR
(KBr, neat) 3528, 2924, 2855, 1598, 1496, 1330, 1159, 1020, 898, 701
cm−1; HRMS (ESI) m/z calcd for C15H22NO5S (M + H)+ 328.1213,
found 328.1219.
Data for N-(2-hydroxyethyl)-4-methyl-N-(2-phenylallyl)-
benzenesulfonamide (5d): colorless solid; mp 83−85 °C; Rf
(hexane/EtOAc, 7:3) 0.48; yield 596 mg, 90%; 1H NMR (600
MHz, CDCl3) δ 2.44 (s, 3 H), 3.16 (t, J = 5.4 Hz, 2 H), 3.56 (t, J = 5.4
Hz, 2 H), 4.24 (s, 2 H), 5.23 (s, 1 H), 5.50 (s, 1 H), 7.26−7.36 (m, 5
H), 7.46 (d, J = 7.8 Hz, 2 H), 7.67 (d, J = 7.8 Hz, 2 H); 13C NMR
(150 MHz, CDCl3) δ 21.7, 50.3, 53.9, 61.2, 117.0, 126.7, 127.7, 128.5,

Data for

128.8, 130.0, 135.4, 138.0, 143.2, 143.9; IR (KBr, neat) 3527, 2925,
1598, 1495, 1334, 1185, 1016, 916, 709 cm−1; HRMS (ESI) m/z calcd
for C18H22NO3S (M + H)+ 332.1315, found 332.1318.

(S)-N-(1-hydroxypropan-2-yl)-4-methyl-N-(2-
phenylallyl)benzenesulfonamide (5e): pale yellow gum; Rf (hex-
ane/EtOAc, 7:3) 0.53; yield 449 mg, 65%; [α]D
25 = +26.0 (c = 0.14,
CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 0.86 (d, J = 6.6 Hz, 3 H),
2.43 (s, 3 H), 3.35 (dd, J = 11.4 and 4.8 Hz,1 H), 3.48 (dd, J = 12.0
and 9.0 Hz, 1 H), 3.91−3.97 (m, 1 H), 4.04 (d, J = 15.6 Hz, 1 H), 4.62
(d, J = 16.2 Hz, 1 H), 5.39 (s, 1 H), 5.45 (s, 1 H), 7.25−7.40 (m, 5 H),
7.46 (t, J = 7.2 Hz, 2 H), 7.69 (d, J = 8.4 Hz, 2 H); 13C NMR (150
MHz, CDCl3) δ 13.6, 21.7, 48.3, 56.2, 65.0, 115.9, 126.9, 127.5, 128.5,
128.8, 130.0, 137.5, 138.6, 143.7, 145.5; IR (KBr, neat) 3538, 2925,
1598, 1495, 1334, 1155, 1026, 912, 738 cm−1; HRMS (ESI) m/z calcd
for C19H24NO3S (M + H)+ 346.1471, found 346.1469.

Data for (S)-N-(1-hydroxy-3-phenylpropan-2-yl)-4-methyl-N-(2-
phenylallyl)benzenesulfonamide (5f): pale yellow oil; Rf (hexane/
25 = −26.0 (c = 0.1,
EtOAc, 4:1) 0.55; yield 598 mg, 71%; [α]D
CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 2.43 (s, 3 H), 2.54 (dd, J =
13.8 and 4.2 Hz, 1 H), 2.73 (dd, J = 13.2 and 10.8 Hz, 1 H), 3.44 (dd,
J = 11.4 and 3.0 Hz, 1 H), 3.57 (dd, J = 12.0 and 9.0 Hz, 1 H), 3.88−
3.94 (m, 1 H), 4.31 (d, J = 16.2 Hz, 1 H), 4.57 (d, J = 16.2 Hz, 1 H),
5.44 (s, 1 H), 5.49 (s, 1 H), 6.93 (d, J = 6.6 Hz, 2 H), 7.16−7.21 (m, 2
H), 7.29 (d, J = 7.8 Hz, 2 H), 7.32−7.36 (m, 4 H), 7.43 (d, J = 8.4 Hz,
2 H), 7.71 (d, J = 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 21.7,
36.0, 49.5, 62.2, 62.4, 116.3, 126.8, 126.9, 127.8, 128.5, 128.8, 128.83,
129.2, 130.0, 137.5, 138.0, 138.6, 143.9, 145.4; IR (KBr, neat) 3479,
2926, 1494, 1331, 1157, 1041, 814, 701 cm−1; HRMS (ESI) m/z calcd
for C25H28NO3S (M + H)+ 422.1784, found 422.1781.

Data for N-(2-hydroxy-2-phenylethyl)-4-methyl-N-(2-
phenylallyl)benzenesulfonamide (5g): colorless gum; Rf (hexane/
EtOAc, 4:1) 0.50; yield 459 mg, 56%; 1H NMR (400 MHz, CDCl3) δ
2.41 (s, 3 H), 3.05 (dd, J = 15.2 and 2.4 Hz, 1 H), 3.25 (dd, J = 15.2
and 9.6 Hz, 1 H), 4.16 (d, J = 14.8 Hz, 1 H), 4.46 (d, J = 14.8 Hz, 1
H), 4.79 (dd, J = 10.0 and 2.4 Hz, 1 H), 5.23 (s, 1 H), 5.54 (s, 1 H),
7.22−7.37 (m, 10 H), 7.45−7.49 (m, 2 H), 7.65 (d, J = 8.4 Hz, 2 H);
13C NMR (150 MHz, CDCl3) δ 21.4, 53.8, 56.1, 72.1, 117.1, 125.7,
126.0, 126.4, 127.2, 127.4, 127.7, 128.3, 128.6, 129.6, 129.7, 137.8,
142.9, 143.7; IR (KBr, neat) 3538, 2925, 1598, 1495, 1334, 1155,
1026, 912, 738 cm−1; HRMS (ESI) m/z calcd for C24H25NNaO3S (M
+ Na)+ 430.1447, found 430.1456.
Data for N-(2-(3-bromophenyl)-2-hydroxyethyl)-4-methyl-N-(2-
methylallyl)benzenesulfonamide (5h): white solid; mp 89−91 °C; Rf
</para>
4354

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Article
<para sub=“exp”>
(hexane/EtOAc, 9:1) 0.39; yield 711 mg, 84%; 1H NMR (600 MHz,
CDCl3) δ 1.70 (s, 3 H), 2.42 (s, 3 H), 3.04 (dd, J = 15.0 and 3.0 Hz, 1
H), 3.31 (dd, J = 15.0 and 9.6 Hz, 1 H), 3.43 (br s, 1 H), 3.58 (d, J =
14.4 Hz, 1 H), 3.92 (d, J = 15.0 Hz, 1 H), 4.86 (d, J = 9.0 Hz, 1 H),
4.89 (s, 1 H), 4.97 (s, 1 H), 7.18 (t, J = 7.8 Hz, 1 H), 7.23 (d, J = 7.8
Hz, 1 H), 7.30 (d, J = 7.8 Hz, 2 H), 7.38 (d, J = 7.8 Hz, 1 H), 7.47 (s, 1
H), 7.70 (d, J = 8.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 20.0,
21.7, 56.4, 56.9, 72.0, 115.7, 122.8, 124.8, 127.5, 129.2, 130.0, 130.2,
131.0, 135.9, 140.8, 144.0, 144.1; IR (KBr, neat) 3482, 2923, 1597,
1427, 1333, 1155, 1091, 922, 655 cm−1; HRMS (ESI) m/z calcd for
C19H23BrNO3S (M + H)+ 424.0577, found 424.0574.

Data for N-(2-(3-bromophenyl)-2-hydroxyethyl)-4-methyl-N-(2-
phenylallyl)benzenesulfonamide (5i): pale yellow gum; Rf (hexane/
EtOAc, 4:1) 0.50; yield 757 mg, 78%; 1H NMR (600 MHz, CDCl3) δ
2.42 (s, 3 H), 3.01−3.07 (m, 2 H), 3.21 (dd, J = 15.0 and 9.0 Hz, 1 H),
4.12 (d, J = 14.4 Hz, 1 H), 4.46 (d, J = 14.4 Hz, 1 H), 4.73 (d, J = 9.6
Hz, 1 H), 5.23 (s, 1 H), 5.56 (s, 1 H), 7.16 (t, J = 7.2 Hz, 2 H), 7.29
(d, J = 7.8 Hz, 2 H), 7.32−7.38 (m, 4 H), 7.40 (s 1 H), 7.48 (d, J = 7.8
Hz, 2 H), 7.65 (d, J = 7.8 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ
21.7, 54.4, 56.3, 71.8, 117.6, 122.8, 124.7, 126.7, 127.7, 128.7, 128.9,
129.1, 130.1, 130.2, 131.0, 135.2, 137.8, 143.1, 143.9, 144.2; IR (KBr,
neat) 3501, 2923, 1597, 1449, 1334, 1157, 1093, 911, 696 cm−1;
HRMS (ESI) m/z calcd for C24H25BrNO3S (M + H)+ 486.0733,
found 486.0730.

Data for N-(2-hydroxy-2-(3-(phenylethynyl)phenyl)ethyl)-4-
methyl-N-(2-phenylallyl)benzenesulfonamide (5j): pale yellow gum;
Rf (hexane/EtOAc, 4:1) 0.40; yield 720 mg, 71%; 1H NMR (600
MHz, CDCl3) δ 2.41 (s, 3 H), 3.02−3.08 (m, 2 H), 3.26 (dd, J = 15.0
and 9.6 Hz, 1 H), 4.15 (d, J = 14.4 Hz, 1 H), 4.47 (d, J = 14.4 Hz, 1
H), 4.79 (d, J = 9.0 Hz, 1 H), 5.25 (s, 1 H), 5.56 (s, 1 H), 7.23 (d, J =
7.8 Hz, 1 H), 7.26−7.36 (m, 9 H), 7.43 (d, J = 7.8 Hz, 2 H), 7.50 (d, J
= 7.8 Hz, 2 H), 7.53 (d, J = 7.8 Hz, 2 H), 7.66 (d, J = 8.4 Hz, 2 H);
13C NMR (150 MHz, CDCl3) δ 21.7, 54.3, 56.3, 72.0, 89.4, 89.8,
117.5, 123.4, 123.6, 126.0, 126.7, 127.7, 128.5, 128.57, 128.6, 128.7,
128.9, 129.2, 130.0, 131.1, 131.8, 135.4, 138.0, 141.9, 143.1, 144.1; IR
(KBr, neat) 3497, 2923, 1599, 1493, 1444, 1334, 1157, 1093, 912, 812,
696 cm−1; HRMS (ESI) m/z calcd for C32H30NO3S (M + H)+
508.1941, found 508.1939.

Data for N-(2-hydroxy-2-(4-(triﬂuoromethyl)phenyl)ethyl)-4-
methyl-N-(2-methylallyl)benzenesulfonamide (5k): colorless gum;
Rf (hexane/EtOAc, 9:1) 0.50; yield 653 mg, 79%; 1H NMR (400
MHz, CDCl3) δ 1.72 (s, 3 H), 2.42 (s, 3 H), 3.05 (d, J = 15.2, 1 H),
3.31 (dd, J = 15.2 and 9.6 Hz, 1 H), 3.58 (d, J = 15.2 Hz, 2 H), 3.95 (d,
J = 14.4 Hz, 1 H), 4.90 (s, 1 H), 4.95−4.99 (m, 2 H), 7.31 (d, J = 8.0
Hz, 2 H), 7.46 (d, J = 8.0 Hz, 2 H), 7.58 (d, J = 8.0 Hz, 2 H), 7.70 (d, J
= 8.0 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 20.0, 21.7, 56.5, 57.0,
72.3, 115.8, 124.3 (q, J = 270.0 Hz), 125.6, 126.5, 127.5, 130.1, 130.2
(q, J = 31.5 Hz), 135.9, 140.9, 144.1, 145.8; 19F NMR (376 MHz,
C6F6/CDCl3): 99.22; IR (KBr, neat) 3502, 2925, 1598, 1417, 1326,
1158, 1123, 1067, 921, 815, 777 cm−1; HRMS (ESI) m/z calcd for
C20H23F3NO3S (M + H)+ 414.1345, found 414.1359.

Data for N-(2-hydroxy-2-(4-methoxyphenyl)ethyl)-4-methyl-N-
(2-methylallyl)benzenesulfonamide (5l): pale yellow gum; Rf
(hexane/EtOAc, 4:1) 0.48; yield 503 mg, 67%; 1H NMR (600
MHz, CDCl3) δ 1.71 (s, 3 H), 2.41 (s, 3 H), 3.03 (dd, J = 15.6 and 3.0
Hz, 1 H), 3.16 (br s, 1 H), 3.35 (dd, J = 15.6 and 9.6 Hz, 1 H), 3.61 (d,
J = 14.4 Hz, 1 H), 3.79 (s, 3 H), 3.90 (d, J = 15.0 Hz, 1 H), 4.85 (d, J =
9.0 Hz, 1 H), 4.88 (s, 1 H), 4.96 (s, 1 H), 6.86 (d, J = 9.0 Hz, 2 H),
7.24 (d, J = 9.0 Hz, 2 H), 7.29 (d, J = 7.8 Hz, 2 H), 7.71 (d, J = 8.4 Hz,
2 H); 13C NMR (150 MHz, CDCl3) δ 20.1, 21.7, 55.5, 56.6, 56.7, 72.2,
114.1, 115.5, 127.3, 127.5, 130.0, 133.9, 136.3, 141.0, 143.9, 159.5; IR
(KBr, neat) 3508, 2924, 1612, 1514, 1444, 1334, 1156, 1033, 919, 656
cm−1; Anal. Calcd for C20H26NO4S: C 63.97, H 6.71, N 3.73, found C
64.05, H 6.76, N 3.64.

Data for N-(2-hydroxyphenyl)-4-methyl-N-(2-phenylallyl)-
benzenesulfonamide (5m): pale yellow gum; Rf (hexane/EtOAc,
7:3) 0.57; yield 570 mg, 75%; 1H NMR (400 MHz, CDCl3) δ 2.45 (s,
3 H), 4.94 (s, 1 H), 5.26 (s, 1 H), 5.68 (s, 1 H), 6.32 (d, J = 8.4 Hz, 1
H), 6.50 (t, J = 8.6 Hz, 1 H), 6.87 (d, J = 8.4 Hz, 1 H), 7.13 (t, J = 7.6
Hz, 1 H), 7.26−7.45 (m, 8 H), 7.52 (d, J = 8.4 Hz, 2 H); 13C NMR

(150 MHz, CDCl3) δ 21.9, 55.6, 117.4, 117.8, 120.1, 124.9, 126.8,
127.5, 128.5, 128.6, 128.9, 129.8, 130.1, 133.7, 137.7, 142.2, 144.6,
155.3; IR (KBr, neat) 3508, 2852, 1597, 1493, 1344, 1161, 1091, 814,
704 cm−1; HRMS (ESI) m/z calcd for C22H22NO3S (M + H)+
380.1315, found 380.1323.

Data for N-(2-hydroxyethyl)-4-methyl-N-(3-methylbut-3-en-1-yl)-
benzenesulfonamide (5n): colorless oil; Rf (hexane/EtOAc, 7:3) 0.40;
yield 490 mg, 90%; 1H NMR (600 MHz, CDCl3) δ 1.70 (s, 3 H), 2.24
(t, J = 7.8 Hz, 2 H), 2.41 (s, 3 H), 2.57 (br s, 1 H), 3.23 (t, J = 5.4 Hz,
2 H), 3.26 (t, J = 7.8 Hz, 2 H), 3.74 (t, J = 4.8 Hz, 2 H), 4.67 (s, 1 H),
4.76 (s, 1 H), 7.30 (d, J = 7.8 Hz, 2 H), 7.69 (d, J = 7.8 Hz, 2 H); 13C
NMR (100 MHz, CDCl3) δ 21.6, 22.6, 37.0, 48.6, 51.0, 61.4, 112.4,
127.4, 129.9, 136.1, 142.3, 143.7; IR (KBr, neat) 3517, 2931, 1598,
1454, 1378, 1158, 1088, 815, 734 cm−1; HRMS (ESI) m/z calcd for
C14H21NNaO3S (M + Na)+ 306.1134, found 306.1133.

Data for N-(2-hydroxyethyl)-4-methyl-N-(3-methylbut-2-en-1-yl)-
benzenesulfonamide (5o): pale yellow oil; Rf (hexane/EtOAc, 7:3)
0.40; yield 496 mg, 81%; 1H NMR (400 MHz, CDCl3) δ 1.62 (s, 3 H),
1.67 (s, 3 H), 2.43 (s, 3 H), 3.20 (t, J = 5.6 Hz, 2 H), 3.72 (t, J = 4.8
Hz, 2 H), 3.84 (d, J = 7.2 Hz, 2 H), 5.02 (dt, J = 6.8 and 1.6 Hz, 1 H),
7.31 (d, J = 8.4 Hz, 2 H), 7.70 (d, J = 7.6 Hz, 2 H); 13C NMR (100
MHz, CDCl3) δ 18.0, 21.7, 25.9, 47.1, 49.9, 61.4, 119.0, 127.5, 129.9,
136.6, 137.7, 143.6; IR (KBr, neat) 3524, 2926, 1598, 1448, 1336,
1158, 1090, 816, 702 cm−1; HRMS (ESI) m/z calcd for
C14H21NaNO3S (M + Na)+ 306.1134, found 306.1136.

Data for N-(2-hydroxy-2-phenylethyl)-4-methyl-N-(3-methylbut-
3-en-1-yl)benzenesulfonamide (5p): pale yellow gum; Rf (hexane/
EtOAc, 7:3) 0.60; yield 470 mg, 66%; 1H NMR (600 MHz, CDCl3) δ
1.71 (s, 3 H), 2.14 (t, J = 7.2 Hz, 2 H), 2.41 (s, 3 H), 3.05 (dd, J = 13.2
and 6.6 Hz, 2 H), 3.26−3.35 (m, 2 H), 4.68 (s, 1 H), 4.78 (s, 1 H),
4.95 (dd, J = 9.0 and 3.6 Hz, 1 H), 7.28−7.39 (m, 7 H), 7.71 (d, J =
8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 21.7, 22.7, 37.4, 49.1,
57.1, 73.0, 112.5, 126.1, 127.3, 127.5, 128.8, 129.9, 130.0, 141.6, 142.4,
143.8; IR (KBr, neat) 3504, 2924, 1494, 1454, 1329, 1157, 1092, 814,
700 cm−1; HRMS (ESI) m/z calcd for C20H26NO3S (M + H)+
360.1628, found 360.1635.

Data for N-(2-hydroxyethyl)-4-methyl-N-(3-phenylbut-3-en-1-yl)-
benzenesulfonamide (5q): pale yellow gum; Rf (hexane/EtOAc, 7:3)
0.45; yield 492 mg, 67%; 1H NMR (600 MHz, CDCl3) δ 2.41 (s, 3 H),
2.82 (t, J = 7.2 Hz, 2 H), 3.23−3.27 (m, 4 H), 3.73 (t, J = 5.4 Hz, 2 H),
5.01 (s, 1 H), 5.36 (s, 1 H), 7.28 (d, J = 8.4 Hz, 2 H), 7.33 (t, J = 7.2
Hz, 3 H), 7.38 (d, J = 7.8 Hz, 2 H), 7.68 (d, J = 8.4 Hz, 2 H); 13C
NMR (150 MHz, CDCl3) δ 21.7, 35.4, 49.5, 51.6, 61.5, 114.6, 126.1,
127.5, 128.0, 128.7, 130.0, 136.3, 140.1, 143.7, 145.0; IR (KBr, neat)
3427, 2923, 2853, 1494, 1463, 1261, 1154, 1089, 1020, 801, 705 cm−1;
HRMS (ESI) m/z calcd for C19H23NNaO3S (M + Na)+ 368.1291,
found 368.1300.

Data for N-(2-mercaptoethyl)-4-methyl-N-(2-phenylallyl)-
benzenesulfonamide (5s): pale yellow gum; Rf (hexane/EtOAc,
7.3) 0.60; yield 638 mg, 92%; 1H NMR (600 MHz, CDCl3) δ 2.43 (s,
3 H), 2.49 (dd, J = 8.8 and 5.6 Hz, 2 H), 3.21 (dd, J = 10.8 and 8.0 Hz,
2 H), 4.18 (s, 2 H), 5.18 (s, 1 H), 5.46 (s, 1 H), 7.26−7.33 (m, 5 H),
7.41−7.46 (m, 2 H), 7.66 (d, J = 8.0 Hz, 2 H); 13C NMR (150 MHz,
CDCl3) δ 21.7, 35.9, 47.4, 53.2, 117.3, 126.6, 127.5, 128.4, 128.7,
130.0, 135.7, 137.8, 142.7, 143.8; IR (KBr, neat) 3058, 2924, 1597,
1445, 1339, 1159, 1090, 914, 818, 658 cm−1; HRMS (ESI) m/z calcd
for C18H22NO2S2 (M + H)+ 348.1086, found 348.1078.

Data for N-(1-mercaptopropan-2-yl)-4-methyl-N-(2-phenylallyl)-
benzenesulfonamide (5t): pale yellow gum; Rf (hexane/EtOAc, 19:1)
0.30; yield 267 mg, 74%; [α]D
25 = +8.0 (c = 0.1, CH2Cl2); 1H NMR
(600 MHz, CDCl3) δ 1.07 (d, J = 6.6 Hz, 3 H), 2.36−2.41 (m, 1 H),
2.43 (s, 3 H), 2.54−2.59 (m, 1 H), 3.81−3.87 (m, 1 H), 4.07 (d, J =
16.2 Hz, 1 H), 4.49 (d, J = 16.2 Hz, 1 H), 5.36 (s, 1 H), 5.46 (s, 1 H),
7.28−7.32 (m, 3 H), 7.34 (t, J = 7.8 Hz, 2 H), 7.42 (d, J = 7.2 Hz, 2
H), 7.69 (d, J = 7.8 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 16.3,
21.7, 30.0, 48.5, 57.8, 116.3, 126.8, 127.5, 128.3, 128.7, 129.9, 137.6,
138.7, 143.6, 145.1; IR (KBr, neat) 3464, 2925, 2855, 1598, 1495,
1448, 1334, 1154, 1090, 998, 701 cm−1; HRMS (ESI) m/z calcd for
C19H24NO2S2 (M + H)+ 362.1243, found 362.1245.
</para>
4355

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Article
<para sub=“exp”>
Data for (S)-methyl 3-mercapto-2-(4-methyl-N-(2-methylallyl)-
benzenesulfonamido)propanoate (5u): pale yellow gum; Rf (hexane/
EtOAc, 7:3) 0.58; yield 453 mg, 66%; [α]D
25 = +33.0 (c = 0.1, CH2Cl2);
1H NMR (600 MHz, CDCl3) δ 1.76 (s, 3 H), 2.42 (s, 3 H), 2.78 (d, J
= 5.4 Hz, 2 H), 3.05 (d, J = 10.2 Hz, 2 H), 3.57 (s, 3 H), 4.10−4.14
(m, 1 H), 4.81 (s, 1 H), 4.86 (s, 1 H), 5.40 (d, J = 8.4 Hz, 1 H), 7.29
(d, J = 8.4 Hz, 2 H), 7.73 (d, J = 7.8 Hz, 2 H); 13C NMR (150 MHz,
CDCl3) δ 20.6, 21.7, 33.9, 39.9, 52.8, 55.5, 114.7, 127.4, 129.8, 136.9,
140.6, 143.9, 170.8; IR (KBr, neat) 3277, 2923, 2854, 1744, 1598,
1436, 1341, 1160, 1090, 815, 662 cm−1; HRMS (ESI) m/z calcd for
C15H22NO4S2 (M + H)+ 344.0985, found 344.0989.

Data for (S)-methyl 3-mercapto-2-(4-methyl-N-(2-phenylallyl)-
benzenesulfonamido)propanoate (5v): pale yellow gum; Rf (hexane/
EtOAc, 7:3) 0.60; yield 494 mg, 61%; [α]D
25 = +10.0 (c = 0.05,
CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 2.41 (s, 3 H), 2.83 (d, J =
5.4 Hz, 2 H), 3.53 (s, 3 H), 3.57 (s, 2 H), 4.11−4.16 (m, 1 H), 5.21 (s,
1 H), 5.46 (s, 1 H), 7.26−7.30 (m, 3 H), 7.34 (t, J = 7.2 Hz, 2 H), 7.41
(d, J = 7.2 Hz, 2 H), 7.72 (d, J = 8.4 Hz, 2 H); 13C NMR (150 MHz,
CDCl3) δ 21.7, 34.3, 37.1, 52.9, 55.6, 116.2, 126.5, 127.4, 128.1, 128.6,
129.9, 136.9, 139.0, 143.1, 144.0, 170.7; IR (KBr, neat) 3447, 2924,
1742, 1626, 1494, 1444, 1341, 1161, 1092, 908, 779 cm−1; HRMS
(ESI) m/z calcd for C20H24NO4S2 (M + H)+ 406.1141,
found
406.1141.

Data for

(S)-3-mercapto-2-(4-methyl-N-(2-methylallyl)-
benzenesulfonamido)propyl acetate (5w): pale yellow oil; Rf
(hexane/EtOAc, 7:3) 0.42; yield 607 mg, 85%; [α]D
25 = +15.0 (c =
0.1, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 1.75 (s, 3 H), 1.94 (s, 3
H), 2.43 (s, 3 H), 2.54 (d, J = 10.8 Hz, 1 H), 2.56 (d, J = 9.2 Hz, 1 H),
2.93 (d, J = 7.2 Hz, 2 H), 3.58 (dt, J = 12.8 and 5.6 Hz, 1 H), 3.99 (dd,
J = 12.0 and 4.4 Hz, 1 H), 4.18 (dd, J = 11.2 and 5.6 Hz, 1 H), 4.73 (s,
1 H), 4.82 (s, 1 H), 5.01 (d, J = 7.6 Hz, 1 H), 7.31 (d, J = 8.4 Hz, 2 H),
7.77 (d, J = 8.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 20.6, 20.8,
21.7, 33.0, 39.8, 51.9, 64.7, 114.5, 127.3, 129.9, 137.7, 140.7, 143.8,
170.9; IR (KBr, neat) 3450, 2932, 1728, 1616, 1503, 1449, 1350, 1149,
1093, 909, 777 cm−1; HRMS (ESI) m/z calcd for C16H24NO4S2 (M +
H)+ 358.1141, found 358.1140.

Data for N-(1-hydroxy-3-mercaptopropan-2-yl)-4-methyl-N-(2-
phenylallyl)benzenesulfonamide (5x): pale yellow oil; Rf (hexane/
25 = −9.0 (c = 0.4, CH2Cl2);
EtOAc, 3:2) 0.49; yield 566 mg, 75%; [α]D
1H NMR (600 MHz, CDCl3) δ 2.41 (s, 3 H), 2.55 (dd, J = 6.6 and 2.4
Hz, 2 H), 3.29−3.34 (m, 2 H), 3.40 (d, J = 13.8 Hz, 1 H), 3.60 (s, 2
H), 5.07 (s, 1 H), 5.32 (br s, 1 H), 5.37 (s, 1 H), 7.26−7.37 (m, 7 H),
7.75(d, J = 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 21.7, 33.0,
36.8, 54.1, 63.6, 115.8, 126.4, 127.4, 128.2, 128.6, 130.0, 137.2, 139.0,
143.2, 143.9; IR (KBr, neat) 3504, 3279, 2924, 1598, 1494, 1444,
1327, 1157, 1092, 1036, 814, 702 cm−1; HRMS (ESI) m/z calcd for
C19H24NO3S2 (M + H)+ 378.1192, found 378.1193.
General Procedure for the Synthesis of 6a−t and 7u−x. To a
stirred solution of compounds 5a−x (1 mmol) in dichloromethane (5
mL) was added 1.2 equiv of borontriﬂuoride etherate under a nitrogen
atmosphere at room temperature. The resulting solution continuously
stirred for 5 h. After completion of the reaction, the reaction mixture
was quenched by addition of saturated sodium bicarbonate solution (5
mL). The aqueous layer was extracted with dichloromethane (3 × 10
mL), and the organic layer was dried over anhydrous Na2SO4. After
concentration under vacuum, the crude product was puriﬁed using
column chromatography on silica gel with ethyl acetate and hexane as
eluents.
Data for 2,2-dimethyl-4-tosylmorpholine (6a): white solid; mp
92−94 °C; Rf (hexane/EtOAc, 4:1) 0.47; yield 223 mg, 83%; 1H NMR
(600 MHz, CDCl3) δ 1.26 (s, 6 H), 2.44 (s, 3 H), 2.72 (s, 2 H), 2.91
(t, J = 4.8 Hz, 2 H), 3.77 (t, J = 4.8 Hz, 2 H), 7.33 (d, J = 7.8 Hz, 2 H),
7.61 (t, J = 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) 21.7 (2C),
24.6, 45.9, 54.9, 60.4, 71.2, 128.0, 129.9, 132.6, 144.0; IR (KBr, neat)
2978, 2877, 1598, 1351, 1166, 1099, 759 cm−1; HRMS (ESI) m/z
calcd for C13H20NO3S (M + H)+ 270.1158 found 270.1157.
Data for (R)-2,2-dimethyl-5-phenyl-4-tosylmorpholine (6b): pale
yellow solid; mp 77−79 °C; Rf (hexane/EtOAc, 4:1) 0.47; yield 245
25 = −68.5 (c = 0.33, CH2Cl2); 1H NMR (600 MHz,
mg, 71%; [α]D
CDCl3) δ 1.24 (s, 3 H), 1.25 (s, 3 H), 2.37 (s, 3 H), 3.11 (d, J = 13.2

Hz, 1 H), 3.23 (d, J = 12.6 Hz, 1 H), 3.99 (dd, J = 12.0 and 2.4 Hz, 1
H), 4.10 (dd, J = 12.0 and 4.2 Hz, 1 H), 4.71 (t, J = 3.0 Hz, 1 H), 7.16
(d, J = 8.4 Hz, 2 H), 7.21−7.23 (m, 3 H), 7.36−7.38 (m, 2 H), 7.47
(d, J = 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) 21.6, 22.4, 26.7,
50.6, 55.8, 64.7, 71.4, 127.5, 127.9, 128.4, 128.7, 129.5, 137.1, 137.8,
143.3; IR (KBr, neat) 2975, 2872, 1599, 1495, 1340, 1164, 1026, 705
cm−1; HRMS (ESI) m/z calcd for C19H24NO3S (M + H)+ 346.1471
found 346.1471.

Data for (S)-methyl 6,6-dimethyl-4-tosylmorpholine-3-carboxy-
late (6c): pale yellow gum; Rf (hexane/EtOAc, 4:1) 0.50; yield 281
25 = −70.0 (c = 0.1, CH2Cl2); 1H NMR (400 MHz,
mg, 86%; [α]D
CDCl3) δ 1.14 (s, 3 H), 1.26 (s, 3 H), 2.40 (s, 3 H), 3.12 (d, J = 12.4
Hz, 1 H), 3.32 (d, J = 12.8 Hz, 1 H), 3.52 (s, 3 H), 4.00−4.10 (m, 2
H), 4.44 (d, J = 3.6 Hz, 1 H), 7.26 (d, J = 8.0 Hz, 2 H), 7.62 (d, J = 8.4
Hz, 2 H); 13C NMR (100 MHz, CDCl3) 20.8, 21.7, 27.5, 50.6, 52.5,
54.5, 62.5, 71.2, 127.5, 129.6, 136.6, 143.6, 169.7; IR (KBr, neat) 2981,
1339, 1154, 1091, 1049, 905, 815, 741 cm−1; HRMS (ESI) m/z calcd
for C15H22NO5S (M + H)+ 328.1213 found 328.1225.
Data for 2-methyl-2-phenyl-4-tosylmorpholine (6d): pale yellow
solid; mp 126−128 °C; Rf (hexane/EtOAc, 4:1) 0.50; yield 298 mg,
90%; 1H NMR (600 MHz, CDCl3) δ 1.44 (s, 3 H), 2.45 (s, 3 H),
2.71−2.78 (m, 2 H), 3.13 (d, J = 11.4 Hz, 1 H), 3.62−3.68 (m, 1 H),
3.72−3.79 (m, 2 H), 7.28 (d, J = 7.8 Hz, 1 H), 7.34−7.39 (m, 4 H),
7.47 (d, J = 7.8 Hz, 2 H), 7.65 (d, J = 7.8 Hz, 2 H); 13C NMR (100
MHz, CDCl3) 21.6, 28.1, 45.7, 52.7, 60.7, 75.1, 126.1, 127.3, 127.9,
128.6, 129.9, 132.1, 142.7, 144.0; IR (KBr, neat) 2977, 2853, 1599,
1458, 1351, 1168, 1093, 802, 701 cm−1; HRMS (ESI) m/z calcd for
C18H22NO3S (M + H)+ 332.1315 found 332.1318.

Data for (2S,5S)-2,5-dimethyl-2-phenyl-4-tosylmorpholine (6e):
pale yellow oil; Rf (hexane/EtOAc, 4:1) 0.60; yield 255 mg, 74%; [α]D
25
= +48.0 (c = 0.1, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 1.02 (d, J =
6.6 Hz, 3 H), 1.58 (s, 3 H), 2.41 (s, 3 H), 3.26 (d, J = 12.6 Hz, 1 H),
3.52 (d, J = 11.4 and 2.4 Hz, 2 H), 3.84−3.88 (m, 1 H), 4.07−4.10 (m,
1 H), 7.26−7.30 (m, 3 H), 7.37 (t, J = 7.2 Hz, 2 H), 7.47 (d, J = 7.2
Hz, 2 H), 7.68 (d, J = 7.8 Hz, 2 H); 13C NMR (100 MHz, CDCl3)
13.5, 21.7, 22.6, 49.0, 49.5, 65.9, 74.7, 124.9, 127.3, 127.5, 128.6, 129.9,
137.1, 143.6, 144.9; IR (KBr, neat) 2978, 2874, 1590, 1447, 1338,
1152, 1021, 800, 701 cm−1; HRMS (ESI) m/z calcd for C19H24NO3S
(M + H)+ 346.1471 found 346.1471.
Data for (2S,5S)-5-benzyl-2-methyl-2-phenyl-4-tosylmorpholine
(6f): pale yellow solid; mp 95−97 °C; Rf (hexane/EtOAc, 4:1) 0.65;
yield 265 mg, 63%; [α]D
25 = +26.0 (c = 0.1, CH2Cl2); 1H NMR (600
MHz, CDCl3) δ 1.60 (s, 3 H), 2.41 (s, 3 H), 2.44 (dd, J = 13.2 and 3.0
Hz, 1 H), 3.03 (dd, J = 13.2 and 10.8 Hz, 1 H), 3.19 (d, J = 12.6 Hz, 1
H), 3.64 (d, J = 12.0 Hz, 1 H), 3.77 (d, J = 12.6 Hz, 1 H), 3.93−3.99
(m, 2 H), 7.14 (d, J = 7.2 Hz, 2 H), 7.21 (t, J = 7.2 Hz, 1 H), 7.27−
7.33 (m, 5 H), 7.40 (t, J = 7.8 Hz, 2 H), 7.53 (d, J = 7.8 Hz, 2 H), 7.71
(d, J = 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) 21.5, 21.7, 32.3,
49.7, 54.4, 61.1, 74.2, 124.7, 126.8, 127.2, 127.6, 128.7, 128.9, 129.7,
130.1, 137.8, 138.0, 143.7, 145.4; IR (KBr, neat) 2924, 2872, 1599,
1448, 1339, 1165, 1052, 814, 702 cm−1; HRMS (ESI) m/z calcd for
C25H28NO3S (M + H)+ 422.1784 found 422.1782.
(2S*,6R*)-2-methyl-2,6-diphenyl-4-tosylmorpholine
(6g): pale yellow solid; mp 191−193 °C; Rf (hexane/EtOAc, 4:1)
0.70; yield 180 mg, 79%; 1H NMR (400 MHz, CDCl3) δ 1.83 (s, 3 H),
2.14 (t, J = 10.8 Hz, 1 H), 2.29 (d, J = 11.4 Hz, 1 H), 2.37 (s, 3 H),
3.87 (dd, J = 10.8 and 2.4 Hz, 1 H), 5.18 (dd, J = 10.2 and 3.0 Hz, 1
H), 7.24 (d, J = 7.2 Hz, 2 H), 7.27−7.45 (m, 8 H), 7.52 (d, J = 7.8 Hz,
1 H), 7.55 (d, J = 7.8 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 21.7,
22.3, 52.5, 54.8, 71.4, 75.4, 124.7, 126.5, 127.6, 127.9, 128.4, 128.6,
128.8, 130.0, 132.6, 139.5, 144.1, 145.3; IR (KBr, neat) 2928, 1558,
1447, 1351, 1168, 1091, 999, 699 cm−1; HRMS (ESI) m/z calcd for
C24H26NO3S (M + H)+ 408.1628 found 408.1644.
Data for (2S*,6R*)-6-(3-bromophenyl)-2,2-dimethyl-4-tosylmor-
pholine (6h): white solid; mp 150−152 °C; Rf (hexane/EtOAc, 9:1)
0.65; yield 343 mg, 81%; 1H NMR (600 MHz, CDCl3) δ 1.27 (s, 3 H),
1.47 (s, 3 H), 1.99 (t, J = 10.8 Hz, 1 H), 2.14 (d, J = 11.4 Hz, 1 H),
2.42 (s, 3 H), 3.47 (dd, J = 10.8 and 1.2 Hz, 1 H), 3.73 (dd, J = 9.6 and
1.8 Hz, 1 H), 4.87 (dd, J = 10.8 and 3.0 Hz, 1 H), 7.19 (t, J = 7.8 Hz, 1
H), 7.22 (t, J = 7.2 Hz, 1 H), 7.31 (d, J = 7.8 Hz, 2 H), 7.40 (d, J = 7.8
</para>
Data for

4356

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Article

Data for

Data for
<para sub=“exp”>
Hz, 1 H), 7.48 (s, 1 H), 7.58 (d, J = 8.4 Hz, 2 H); 13C NMR (150
MHz, CDCl3) δ 21.7, 21.8, 28.0, 52.0, 54.4, 70.8, 72.3, 122.8, 125.1,
127.9, 129.4, 130.0, 130.2, 131.4, 132.6, 141.7, 144.1; IR (KBr, neat)
2978, 1597, 1453, 1352, 1165, 1093, 998, 694 cm−1; HRMS (ESI) m/z
calcd for C19H23BrNO3S (M + H)+ 424.0577, found 424.0576.
Data for (2S*,6R*)-6-(3-bromophenyl)-2-methyl-2-phenyl-4-to-
sylmorpholine (6i): white solid; mp 134−136 °C; Rf (hexane/EtOAc,
9:1) 0.48; yield 417 mg, 86%; 1H NMR (600 MHz, CDCl3) δ 1.82 (s,
3 H), 2.10 (t, J = 11.4 Hz, 1 H), 2.29 (d, J = 11.4 Hz, 1 H), 2.38 (s, 3
H), 3.85 (d, J = 11.4 Hz, 2 H), 5.14 (dd, J = 10.2 and 2.4 Hz, 1 H),
7.23−7.28 (m, 3 H), 7.30 (t, J = 7.8 Hz, 1 H), 7.34−7.40 (m, 4 H),
7.50 (d, J = 7.8 Hz, 2 H), 7.57 (d, J = 8.4 Hz, 2 H), 7.60 (s, 1 H); 13C
NMR (150 MHz, CDCl3) δ 21.7, 22.3, 52.3, 54.7, 70.9, 75.7, 122.9,
124.6, 125.1, 127.7, 127.9, 128.7, 129.5, 130.1, 130.3, 131.6, 132.6,
141.8, 144.2, 145.0; IR (KBr, neat) 2984, 1597, 1449, 1344, 1164,
1091, 999, 756, 694 cm−1; HRMS (ESI) m/z calcd for C24H25BrNO3S
(M + H)+ 486.0733, found 486.0731.
(2S*,6R*)-2-methyl-2-phenyl-6-(3-(phenylethynyl)-
phenyl)-4-tosylmorpholine (6j): colorless gum; Rf (hexane/EtOAc,
9:1) 0.38; yield 370 mg, 73%; 1H NMR (600 MHz, CDCl3) δ 1.84 (s,
3 H), 2.14 (t, J = 11.4 Hz, 1 H), 2.31 (d, J = 11.4 Hz, 1 H), 2.38 (s, 3
H), 3.87 (d, J = 9.6 Hz, 2 H), 5.18 (dd, J = 10.8 and 3.0 Hz, 1 H), 7.31
(d, J = 7.2 Hz, 2 H), 7.35−7.41 (m, 7 H), 7.50 (d, J = 7.8 Hz, 2 H),
7.52−7.55 (m, 4 H), 7.57 (d, J = 8.4 Hz, 2 H), 7.61 (s, 1 H); 13C
NMR (150 MHz, CDCl3) δ 21.7, 22.4, 52.4, 54.8, 71.2, 75.6, 89.2,
90.0, 123.3, 123.8, 124.7, 125.1, 126.4, 127.7, 127.9, 128.6, 128.63,
128.8, 129.6, 130.1, 131.6, 131.9, 132.6, 139.8, 144.1, 145.2; IR (KBr,
neat) 2924, 1600, 1493, 1450, 1348, 1165, 1094, 1002, 909, 697 cm−1;
HRMS (ESI) m/z calcd for C32H30NO3S (M + H)+ 508.1941, found
508.1947.
(2S*,6R*)-2,2-dimethyl-4-tosyl-6-(4-(triﬂuoromethyl)-
phenyl)morpholine (6k): colorless solid; mp 141−143 °C; Rf
(hexane/EtOAc, 9:1) 0.65; yield 380 mg, 92%; 1H NMR (600
MHz, CDCl3) δ 1.29 (s, 3 H), 1.49 (s, 3 H), 2.00 (t, J = 10.8 Hz, 1 H),
2.16 (d, J = 11.4 Hz, 1 H), 2.43 (s, 3 H), 3.49 (dd, J = 11.4 and 1.2 Hz,
1 H), 3.78 (dt, J = 10.8 and 1.2 Hz, 1 H), 4.96 (dd, J = 10.8 and 3.0
Hz, 1 H), 7.31 (d, J = 8.4 Hz, 2 H), 7.44 (d, J = 8.4 Hz, 2 H), 7.57−
7.60 (m, 4 H); 13C NMR (150 MHz, CDCl3) δ 21.7, 21.8, 28.0, 52.0,
54.5, 71.0, 72.4, 124.2 (q, J = 270.0 Hz), 125.6, 126.8, 127.9, 130.1,
130.5 (q, J = 33.0 Hz), 132.6, 143.4, 144.2; 19F NMR (376 MHz,
C6F6/CDCl3): 99.12; IR (KBr, neat) 2926, 1599, 1454, 1325, 1165,
1093, 1029, 941, 667 cm−1; HRMS (ESI) m/z calcd for
C20H23F3NO3S (M + H)+ 414.1345, found 414.1343.
Data for 2-methyl-2-phenyl-4-tosyl-3,4-dihydro-2H-benz[b][1,4]-
oxazine (6m): colorless solid; mp 119−121 °C; Rf (hexane/EtOAc,
4:1) 0.73; yield 258 mg, 68%; 1H NMR (600 MHz, CDCl3) δ 1.67 (s,
3 H), 2.34 (s, 3 H), 3.97 (d, J = 12.6 Hz, 1 H), 4.14 (d, J = 12.6 Hz, 1
H), 6.77−6.80 (m, 1 H), 6.95−6.98 (m, 1 H), 7.02 (dd, J = 7.8 and 1.2
Hz, 1 H), 7.15 (d, J = 7.8 Hz, 1 H), 7.32 (t, J = 7.2 Hz, 1 H), 7.36 (t, J
= 7.2 Hz, 2 H), 7.44−7.50 (m, 6 H); 13C NMR (150 MHz, CDCl3) δ
21.7, 26.0, 53.0, 77.5, 118.2, 119.0, 120.9, 124.5, 124.6, 125.3, 127.4,
127.9, 128.9, 129.9, 136.7, 142.6, 144.1, 144.7; IR (KBr, neat) 2927,
2869, 1598, 1493, 1352, 1165, 1090, 813, 700 cm−1; HRMS (ESI) m/z
calcd for C22H22NO3S (M + H)+ 380.1315 found 380.1316.
Data for 7,7-dimethyl-4-tosyl-1,4-oxazepane (6n): colorless solid;
mp 62−64 °C; Rf (hexane/EtOAc, 4:1) 0.50; yield 263 mg, 93%; 1H
NMR (600 MHz, CDCl3) δ 1.13 (s, 6 H), 1.91 (t, J = 4.8 Hz, 2 H),
2.42 (s, 3 H), 3.20−3.23 (m, 4 H), 3.70 (t, J = 4.2 Hz, 2 H), 7.31 (d, J
= 7.8 Hz, 2 H), 7.64 (d, J = 8.4 Hz, 2 H); 13C NMR (100 MHz,
CDCl3) δ 21.5, 27.7 (2C), 41.3, 43.8, 51.3, 62.6, 76.9, 127.3, 129.7,
134.8, 143.4; IR (KBr, neat) 2973, 2870, 1598, 1452, 1385, 1163,
1034, 862, 718 cm−1; HRMS (ESI) m/z calcd for C14H22NO3S (M +
H)+ 284.1315 found 284.1316.
Data for 7,7-dimethyl-2-phenyl-4-tosyl-1,4-oxazepane (6p):
yellow solid; mp 137−139 °C; Rf (hexane/EtOAc, 4:1) 0.68; yield
258 mg, 72%; 1H NMR (600 MHz, CDCl3) δ 1.20 (s, 3 H), 1.21 (s, 3
H), 1.96 (dd, J = 15.6 and 7.2 Hz, 1 H), 2.13 (dd, J = 15.6 and 9.6
Hz,1 H), 2.42 (s, 3 H), 2.66 (dd, J = 12.6 and 9.6 Hz, 1 H), 2.83 (dd, J
= 13.8 and 10.2 Hz, 1 H), 3.88 (dd, J = 13.2 and 7.8 Hz, 1 H), 3.98 (d,
J = 12.6 Hz, 1 H), 4.84 (d, J = 9.6 Hz, 1 H), 7.26−7.35 (m, 7 H), 7.63

(d, J = 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 21.7, 26.5, 29.5,
42.3, 44.0, 57.0, 73.9, 75.2, 126.1, 127.4, 127.7, 128.5, 129.9, 135.5,
141.0, 143.5; IR (KBr, neat) 2972, 2927, 1598, 1449, 1339, 1162,
1026, 890, 724 cm−1; HRMS (ESI) m/z calcd for C20H26NO3S (M +
H)+ 360.1628 found 360.1631.

Data for 7-methyl-7-phenyl-4-tosyl-1,4-oxazepane (6q): colorless
gum; Rf (hexane/EtOAc, 7:3) 0.58; yield 275 mg, 75%; 1H NMR (600
MHz, CDCl3) δ 1.44 (s, 3 H), 2.45 (s, 3 H), 2.72 (d, J = 12.0 Hz, 1
H), 2.76 (d, J = 8.4 Hz,1 H), 3.12 (d, J = 11.4 Hz, 1 H), 3.62−3.67 (m,
2 H), 3.73−3.79 (m, 3 H), 7.28 (t, J = 7.2 Hz, 1 H), 7.35 (d, J = 7.8
Hz, 2 H), 7.38 (t, J = 7.8 Hz, 2 H), 7.47 (d, J = 8.4 Hz, 2 H), 7.64 (d, J
= 8.4 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 21.8, 28.3, 29.9, 45.9,
52.8, 60.9, 75.3, 126.3, 127.5, 128.1, 128.9, 130.0, 132.4, 142.8, 144.1;
IR (KBr, neat) 2923, 2853, 1530, 1453, 1349, 1165, 1092, 761, 660
cm−1; HRMS (ESI) m/z calcd for C19H23NNaO3S (M + Na)+
368.1291 found 368.1288.
Data for 2-methyl-2-phenyl-4-tosylthiomorpholine (6s): pale
yellow solid; mp 121−123 °C; Rf (hexane/EtOAc, 4:1) 0.70; yield
243 mg, 70%; 1H NMR (400 MHz, CDCl3) δ 1.65 (s, 3 H), 2.44 (s, 3
H), 2.56−2.64 (m, 1 H), 2.75−2.82 (m, 1 H), 3.18−3.30 (m, 2 H),
3.32−3.39 (m, 1 H), 3.87 (d, J = 11.6 Hz, 1 H), 7.26 (t, J = 7.6 Hz, 1
H), 7.31−7.38 (m, 4 H), 7.62 (d, J = 8.4 Hz, 2 H), 7.67 (d, J = 8.0 Hz,
2 H); 13C NMR (100 MHz, CDCl3) δ 21.7, 26.2, 46.5, 47.5 (2C),
57.6, 127.0, 127.4, 127.7, 128.7, 130.0, 133.8, 143.3, 144.0; IR (KBr,
neat) 2922, 2853, 1597, 1494, 1454, 1338, 1285, 1164, 1089, 899, 762
cm−1; HRMS (ESI) m/z calcd for C18H22NO2S2 (M + H)+ 348.1086,
found 348.1080.

Data for 2,5-dimethyl-2-phenyl-4-tosylthiomorpholine (6t): pale
yellow gum; Rf (hexane/EtOAc, 19:1) 0.30; yield 311 mg, 86%; [α]D
25
= +42.83 (c = 0.6, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 1.12 (d, J
= 6.6 Hz, 3 H), 1.85 (s, 3 H), 2.35 (d, J = 13.2 Hz, 1 H), 2.42 (s, 3 H),
3.44−3.50 (m, 1 H), 3.85 (d, J = 13.2 Hz, 1 H), 4.48 (br s, 1 H),
7.27−7.31 (m, 3 H), 7.38 (t, J = 7.8 Hz, 2 H), 7.60 (d, J = 7.8 Hz, 2
H), 7.66 (d, J = 7.8 Hz, 2 H); 13C NMR (150 MHz, CDCl3) δ 13.5,
21.7, 24.0, 32.2, 45.4, 46.8, 51.2, 126.4, 127.1, 127.8,, 129.9, 137.9,
143.4, 143.7; IR (KBr, neat) 2924, 2855, 1598, 1495, 1446, 1337,
1167, 1029, 995, 697 cm−1; HRMS (ESI) m/z calcd for C19H24NO2S2
(M + H)+ 362.1243, found 362.1248.

Data for

(2S,4S)-methyl 2-isopropyl-3-tosylthiazolidine-4-car-
boxylate (7u): yellow gum; Rf (hexane/EtOAc, 4:1) 0.56; yield 226
25 = −2.0 (c = 0.06, CH2Cl2); 1H NMR (600 MHz,
mg, 66%; [α]D
CDCl3) δ 0.98 (d, J = 6.6 Hz, 3 H), 1.11 (d, J = 6.6 Hz, 3 H),1.88−
1.95 (m, 1 H), 2.44 (s, 3 H), 2.82 (dd, J = 11.4 and 7.8 Hz, 1 H), 3.23
(dd, J = 11.4 and 6.0 Hz, 1 H), 3.78 (s, 3 H), 4.61 (t, J = 6.6 Hz, 1 H),
4.71 (d, J = 8.4 Hz, 1 H), 7.33 (d, J = 8.4 Hz, 2 H), 7.74 (d, J = 8.4 Hz,
2 H); 13C NMR (100 MHz, CDCl3) δ 19.3, 20.5, 21.8, 33.9, 36.1, 53.1,
65.3, 74.9, 128.1, 130.1, 134.5, 144.6, 170.8; IR (KBr, neat) 2959,
2924, 1742, 1438, 1350, 1164, 1090, 1009, 815, 661 cm−1; HRMS
(ESI) m/z calcd for C15H22NO4S2 (M + H)+ 344.0985 found
344.0984.

Data for (2S,4S)-methyl 2-(1-phenylethyl)-3-tosylthiazolidine-4-
carboxylate (7v, two diastereomers with a ratio of 7:3): pale yellow
25 = −5.0 (c
gum; Rf (hexane/EtOAc, 4:1) 0.50; yield 288 mg, 71%; [α]D
= 0.08, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 1.43 (d, J = 7.2 Hz, 3
H, minor), 1.54 (d, J = 7.2 Hz, 3 H, major), 2.41 (s, 3 H, minor), 2.43
(s, 3 H, major), 2.72 (dd, J = 11.4 and 7.8 Hz, 1 H, major), 2.92 (dd, J
= 11.4 and 7.8 Hz, 1 H, minor), 3.00−3.06 (m, 2 H, major), 3.30 (dd,
J = 11.4 and 6.6 Hz, 1 H, minor), 3.49 (dd, J = 11.4 and 6.0 Hz, 1 H,
minor), 3.78 (s, 3 H, minor), 3.80 (s, 3 H, major), 4.57−4.62 (m, 2 H,
major, minor), 5.15 (d, J = 9.6 Hz, 1 H, major), 5.18 (d, J = 6.6 Hz, 1
H, minor), 7.22−7.34 (m, 14 H, major, minor), 7.59 (d, J = 7.8 Hz, 2
H, minor), 7.77 (d, J = 8.4 Hz, 2 H, major); 13C NMR (150 MHz,
CDCl3) δ 20.3, 21.7, 21.8, 22.9, 33.9, 34.0, 46.2, 48.0, 53.0, 53.1, 65.6,
66.2, 74.0, 74.1, 127.1, 127.2, 128.1, 128.2, 128.3, 128.5, 128.6, 130.0,
130.2, 134.1, 134.4, 142.8, 142.9, 144.6, 144.8, 170.5, 170.7; IR (KBr,
neat) 2924, 2853, 1747, 1597, 1494, 1453, 1352, 1165, 1091, 815, 701
cm−1; HRMS (ESI) m/z calcd for C20H24NO4S2 (M + H)+ 406.1141
found 406.1143.

Data for

((2S,4S)-2-isopropyl-3-tosylthiazolidin-4-yl)methanol
(7w): yellow oil; Rf (hexane/EtOAc, 7:3) 0.30; yield 186 mg, 59%;
</para>
4357

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

The Journal of Organic Chemistry

Article
<para sub=“exp”>
25 = −40.0 (c = 0.1, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 1.01
[α]D
(d, J = 6.6 Hz, 3 H), 1.13 (d, J = 6.6 Hz, 3 H), 1.93−1.99 (m, 1 H),
2.45 (s, 3 H), 2.66 (dd, J = 12.0 and 7.2 Hz, 1 H), 2.80 (dd, J = 12.0
and 6.0 Hz, 1 H), 3.74 (d, J = 6.0 Hz, 2 H), 4.01−4.06 (m, 1 H), 4.72
(d, J = 9.0 Hz, 1 H), 7.34 (d, J = 7.8 Hz, 2 H), 7.73 (d, J = 7.8 Hz, 2
H); 13C NMR (150 MHz, CDCl3) δ 19.6, 20.8, 21.8, 33.2, 36.1, 65.2,
66.3, 75.3, 128.3, 130.1, 134.3, 144.6; IR (KBr, neat) 3412, 2924, 2854,
1712, 1637, 1462, 1344, 1161, 1090, 1037, 812, 661, 584, 550 cm−1;
HRMS (ESI) m/z calcd for C14H22NO3S2 (M + H)+ 316.1036 found
316.1035.

Data for

((2S,4S)-2-(1-phenylethyl)-3-tosylthiazolidin-4-yl)-
methanol (7x, diastereomeric mixture with a ratio of 3:2): pale
yellow gum; Rf (hexane/EtOAc, 3:2) 0.75; yield 279 mg, 74%; [α]D
25 =
+32.0 (c = 0.3, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 1.42 (d, J =
6.6 Hz, 3 H, minor), 1.46 (d, J = 7.2 Hz, 3 H, major), 2.33 (br s, 1 H),
2.42 (s, 3 H, minor), 2.44 (s, 3 H, major), 2.49 (d, J = 6.0 Hz, 2 H,
major), 2.60 (dd, J = 12.0 and 7.2 Hz, 1 H, minor), 2.80 (dd, J = 12.0
and 4.8 Hz, 1 H, minor), 3.28 (pentet, J = 7.2 Hz, 1 H, major), 3.35
(dd, J = 10.8 and 5.4 Hz, 1 H, major), 3.40 (dd, J = 11.4 and 6.6 Hz, 1
H, major), 3.48 (pentet, J = 6.6 Hz, 1 H, minor), 3.74 (dd, J = 10.8 and
6.0 Hz, 1 H, minor), 3.80 (dd, J = 11.4 and 6.6 Hz, 1 H, minor), 3.96
(pentet, J = 6.6 Hz, 1 H, major), 4.06 (pentet, J = 6.6 Hz, 1 H, minor),
5.15 (d, J = 7.8 Hz, 1 H, major), 5.21 (d, J = 6.6 Hz, 1 H, minor),
7.25−7.36 (m, 7 H), 7.62 (d, J = 8.4 Hz, 2 H, minor), 7.76 (d, J = 8.4
Hz, 2 H, major); 13C NMR (150 MHz, CDCl3) δ 14.3, 14.4, 19.9,
21.3, 21.8, 22.9, 32.1, 33.1, 46.6, 47.2, 64.5, 64.7, 74.2, 74.3, 127.3,
127.5, 128.2, 128.3, 128.5, 128.7, 129.2, 130.1, 130.2, 134.1, 142.0,
142.7, 144.6, 144.7; IR (KBr, neat) 3421, 2926, 1598, 1454, 1346,
1162, 1091, 1035, 813, 661 cm−1; HRMS (ESI) m/z calcd for
C19H24NO3S2 (M + H)+ 378.1192 found 378.1191.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
1H and 13C NMR and HRMS spectra of all new compounds,
NOE spectra of compound 7u, and crystal parameters, ORTEP
diagrams, and crystallographic data in CIF format
for
compounds 6f,g. This material is available free of charge via
the Internet at http://pubs.acs.org.

■ AUTHOR INFORMATION
Corresponding Author
*Fax: +91-361-2690762. E-mail: asaikia@iitg.ernet.in.
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

M.J.D. gratefully acknowledges the Council of Scientiﬁc and
Industrial Research (CSIR), New Delhi, for his fellowship. We
are grateful to the CSIR for ﬁnancial support (Grant 02/0159/
13/EMR-II). We are also thankful to the Central Instrument
Facility (CIF) of the Indian Institute of Technology (IIT)
Guwahati for the NMR and XRD facilities.

■ REFERENCES
(1) (a) Wijtmans, R.; Vink, M. K. S.; Schoemaker, H. E.; van Delft, F.
L.; Blaauw, R. H.; Rutjes, F. P. J. T. Synthesis 2004, 641−662.
(b) Audouze, K.; Nielson, E. Ø.; Peters, D. J. Med. Chem. 2004, 47,
3089−3104. (c) Sharma, G.; Park, J. Y.; Park, M. S. Bioorg. Med. Chem.
Lett. 2008, 18, 3188−3191. (d) Grinsteiner, T. J.; Kishi, Y. Tetrahedron
Lett. 1994, 35, 8333−8336. (e) Grinsteiner, T. J.; Kishi, Y. Tetrahedron
Lett. 1994, 35, 8337−8340.
(2) (a) Hajos, M.; Fleishaker, J. C.; Filipiak-Reisner, J. K.; Brown, M.
T.; Wong, E. H. F. CNS Drug Rev. 2004, 10, 23−44. (b) Versiani, M.;
Cassano, G.; Perugi, G.; Benedetti, A.; Mastalli, L.; Nardi, A.; Savino,
M. J. Clin. Psychiatry 2002, 63, 31−37. (c) Wong, E. H. F.; Sonders, M.
S.; Amara, S. G.; Tinholt, P. M.; Piercey, M. F. P.; Hoffmann, W. P.;

Hyslop, D. K.; Franklin, S.; Porsolt, R. D.; Bonsignori, A.; Carfagna,
N.; McArthur, R. A. Biol. Psychiatry 2000, 47, 818−829.
(3) (a) Ancliﬀ, R. A.; Cook, C. M.; Eldred, C. D.; Gore, P. M.;
Harrison, L. A.; Hayes, M. A.; Hodgson, S. T.; Judd, D. B.; Keeling, S.
E.; Lewell, X. Q.; Mills, G.; Robertson, G. M.; Swanson, S.; Walker, A.
J.; Wilkinson, M. PCT Int. Appl. WO 03082861, 2003. (b) Ong, J.;
Kerr, D. I. B.; Bittiger, H.; Waldmeier, P. C.; Baumann, P. A.; Cooke,
N. G.; Mickel, S. J.; Froestl, W. Eur. J. Pharmacol. 1998, 362, 27−34.
(c) Kuo, S.-C.; Blythin, D. J.; Kreutner, W. U.S. Patent 5929236, 1999.
(4) Khamrai, U.; Karak, S. K.; Ronsheim, M.; Saha, A. K. U.S. Patent
068191, 2010.
(5) (a) Bowers, W. S.; Ebing, W.; Fukuto, T. R.; Martin, D. Chemistry
of Plant Protection; Springer: Berlin, 1986; Vol. 1, pp 55−56.
(b) Worthing, C. R. The Pesticide Manual, 7th ed.; British Crop
Protection Council: Alton, Hampshire, U.K., 1983; pp 265 and 550.
(6) (a) Licandro, E.; Maiorana, S.; Papagni, A.; Pryce, M.; Zanotti-
Gerosa, A.; Rivaa, S. Tetrahedron: Asymmetry 1995, 6, 1891−1894.
(b) Baldoli, C.; Del Buttero, P.; Licandro, E.; Maiorana, S.; Papagni, S.;
J. Organomet. Chem. 1995, 486, 279−282.
Zanotti-Gerosa, A.
(c) Enders, D.; Meyer, O.; Raabe, G.; Runsink, J. Synthesis 1994,
66−72.
(7) (a) MacLeod, G.; Ames, J. Flavour Fragrance J. 1986, 1, 91−107.
(b) MacLeod, G.; Ames, J. J. Food Sci. 1987, 52, 42−46. (c) Ong, P.;
Acree, T. J. Agric. Food Chem. 1998, 46, 2282−2286.
(8) (a) Wipf, P.; Fritch, P. Tetrahedron Lett. 1994, 35, 5377−5400.
(b) Pattenden, G.; Boden, C.; Ye, T. Synlett 1995, 417−419. (c) Paul,
B.; Korytnyk, W. J. Med. Chem. 1976, 19, 1002−1007.
(9) Cook, A. H.; Heilborn, I. M. The Chemistry of Penicilin; Princeton
University Press: Princeton, NJ, 1949; pp 921−972.
(10) Oya, M.; Kato, E.; Iwao, J.; Yasuoka, N. Chem. Pharm. Bull.
1982, 30, 484−493.
(11) Haack, T.; Mutter, M. Tetrahedron Lett. 1992, 33, 1589−1592.
(12) (a) Ritzen, B.; Hoekman, S.; Verdasco, E. D.; van Delft, F. L.;
Rutjes, F. P. J. T. J. Org. Chem. 2010, 75, 3461−3464. (b) Lanman, B.
A.; Myers, A. G. Org. Lett. 2004, 6, 1045−1047.
(13) Yar, M.; McGarrigle, E. M.; Aggarwal, V. K. Org. Lett. 2009, 11,
257−260.
(14) Wilkinson, M. C. Tetrahedron Lett. 2005, 46, 4773−4775.
(15) (a) Brenner, E.; Baldwin, R. M.; Tamagnan, G. Org. Lett. 2005,
7, 937−939. (b) Jagtap, R. S.; Joshi, N. N. Tetrahedron: Asymmetry
2011, 22, 1861−1864. (c) O’Reilly, M. C.; Lindsley, C. W. Tetrahedron
Lett. 2012, 53, 1539−1542.
(16) Burland, P. A.; Osborn, H. M.; Turkson, A. Bioorg. Med. Chem.
2011, 19, 5679−5692.
(17) (a) Gharpure, S. J.; Prasad, J. V. K. J. Org. Chem. 2011, 76,
10325−10331. (b) Gharpure, S. J.; Prasad, J. V. K. Eur. J. Org. Chem.
2013, 2076−2079.
(18) Dave, R.; Sasaki, N. A. Org. Lett. 2004, 6, 15−18.
(19) Lupi, V.; Albanese, D.; Landini, D.; Scaletti, D.; Penso, M.
Tetrahedron 2004, 60, 11709−11718.
(20) (a) D’hooghe, M.; Vanlangendonck, T.; Törnroos, K. W.; De
Kimpe, N. J. Org. Chem. 2006, 71, 4678−4681. (b) Ghorai, M. K.;
Shukla, D.; Das, K. J. Org. Chem. 2009, 74, 7013−7022. (c) Bornholdt,
J.; Felding, J.; Kristensen, J. L. J. Org. Chem. 2010, 75, 7454−7457.
(21) Sequeira, F. C.; Chemler, S. R. Org. Lett. 2012, 14, 4482−4485.
(22) (a) Asinger, F.; Thiel, M.; Dathe, W.; Hempel, O.; Mittag, E.;
Pleschil, E.; Schröder, C. Liebigs Ann. Chem. 1961, 639, 146−156.
(b) Schlemminger,
Janknecht, H.-H.; Maison, W.; Saak, W.;
Martens, J. Tetrahedron Lett. 2000, 41, 7289−7292.
(23) (a) Fernandez, X.; Duñach, E. Tetrahedron: Asymmetry 2001, 12,
1279−1286. (b) Patek, M.; Drake, B.; Ledl, M. Tetrahedron Lett. 1995,
36, 2227−2230. (c) Takata, T.; Kuo, M.; Tamura, Y.; Kabe, Y.; Ando,
W. Chem. Lett. 1985, 939−942. (d) Fernandez, X.; Fellous, R.;
Duñach, E. Tetrahedron Lett. 2000, 41, 3381−3384. (e) Calmes, M.;
Escale, F.; Paolini, F. Tetrahedron: Asymmetry 1997, 8, 3691−3697.
(24) (a) Dzudza, A.; Marks, T. J. Org. Lett. 2009, 11, 1523−1526.
(b) Marotta, E.; Foresti, E.; Marcelli, T.; Peri, F.; Righi, P.; Scardovi,
N.; Rosini, G. Org. Lett. 2002, 4, 4451−4453. (c) Yang, C.-G.; He, C. J.
Am. Chem. Soc. 2005, 127, 6966−6967. (d) Sakurai, H.; Kamiya, I.;

I.;

4358

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

Article

The Journal of Organic Chemistry
Kitahara, H. Pure Appl. Chem. 2010, 82, 2005−2016. (e) Loh, T.-P.;
Hu, Q.-Y.; Ma, L.-T. J. Am. Chem. Soc. 2001, 123, 2450−2451.
(f) Guérinot, A.; Serra-Muns, A.; Bensouussan, C.; Reymond, S.;
Cossy, J. Tetrahedron 2011, 67, 5024−5033. (g) Qian, H.; Han, X.;
J. Am. Chem. Soc. 2004, 126, 9536−9537.
Widenhoefer, R. A.
(h) Yang, C.-G.; Reich, N. W.; Shi, Z.; He, C. Org. Lett. 2005, 7,
4553−4556. (i) Dzudza, A.; Marks, T. J. Chem.Eur. J. 2010, 16,
3403−3422. (j) Weiss, C. J.; Marks, T. J. Dalton Trans. 2010, 39,
6576−6588. (k) Weïwer, M.; Coulombel, L.; Duňach, E. Chem.
Commun. 2006, 332−334.
(25) (a) Kuan, K. K. W.; Pepper, H. P.; Bloch, W. M.; George, J. H.
Org. Lett. 2012, 14, 4710−4713. (b) Marcos, L. S.; Conde, A.; Moro,
R. F.; Basabe, P.; Diez, D.; Urones, J. G. Tetrahedron 2010, 66, 8280−
8290. (c) Papahatjis, D. P.; Nahmias, V. R.; Nikas, S. P.; Andreou, T.;
Alapafuja, S. O.; Tsotinis, A.; Guo, J.; Fan, P.; Makriyannis, A. J. Med.
Chem. 2007, 50, 4048−4060. (d) Papahatjis, D. P.; Nahmias, V. R.;
Andreou, T.; Fanb, P.; Makriyannis, A. Bioorg. Med. Chem. Lett. 2006,
16, 1616−1620.
(26) (a) Reddy, U. C.; Raju, B. R.; Kumar, E. K.; Saikia, A. K. J. Org.
Chem. 2008, 73, 1628−1630. (b) Reddy, U. C.; Saikia, A. K. Synlett
2010, 1027−1032. (c) Saha, P.; Reddy, U. C.; Bondalapati, S.; Saikia,
A. K. Org. Lett. 2010, 12, 1824−1826. (d) Saikia, A. K.; Bondalapati,
Indukuri, K.; Gogoi, P. Chem. Lett. 2011, 40, 1176−1178.
S.;
(e) Indukuri, K.; Unnava, R.; Deka, M. J.; Saikia, A. K. J. Org. Chem.
2013, 78, 10629−10641. (f) Saikia, A. K.; Indukuri, K.; Das, J. Org.
Biomol. Chem. 2014, 12, 7026−7035. (g) Sultana, S.; Indukuri, K.;
Deka, M. J.; Saikia, A. K. J. Org. Chem. 2013, 78, 12182−12188.
(h) Bondalapati, S.; Indukuri, K.; Ghosh, P.; Saikia, A. K. Eur. J. Org.
Chem. 2013, 952−956. (i) Bondalapati, S.; Gogoi, P.; Indukuri, K.;
Saikia, A. K. J. Org. Chem. 2012, 77, 2508−2512.
(27) (a) Poornachandran, M.; Raghunathan, R. Tetrahedron 2008,
64, 6461−6474. (b) Bera, S.; Panda, G. ACS Comb. Sci. 2012, 14, 1−4.
(c) Tarantino, K. T.; Liu, P.; Knowles, R. R. J. Am. Chem. Soc. 2013,
135, 10022−10025.
(28) The crystallographic data for compounds 6f,g have been
deposited with the Cambridge Crystallographic Data Centre as
supplementary publication nos. CCDC 1051766 and 1041712,
respectively.

4359

DOI: 10.1021/acs.joc.5b00049
J. Org. Chem. 2015, 80, 4349−4359

